| |
| |
|
| Insider
Information: |
Humer Franz B |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
269,122 |
|
|
Indirect Shares
|
21,304 |
|
|
| Direct
Value |
$166,679 |
|
|
|
Indirect Value
|
$1,330,435 |
|
|
| Total
Shares |
290,426 |
|
|
| Total
Value |
$1,497,114 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Citigroup Inc |
C |
Director |
2019-04-01 |
2,669 |
2019-04-01 |
21,304 |
Premium* |
|
|
Kite Pharma, Inc. |
KITE |
Director |
2017-10-03 |
0 |
2016-03-10 |
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2023-06-13 |
266,453 |
2018-10-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| C |
Citigroup Inc |
Director |
– • – |
2018-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,015 |
4,594 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-04-01 |
4 |
A |
$74.44 |
$826 |
D/D |
11 |
4,605 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-04-01 |
4 |
A |
$74.44 |
$5,797 |
I/I |
78 |
18,167 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-07-01 |
4 |
A |
$67.57 |
$1,476 |
D/D |
22 |
4,627 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-07-01 |
4 |
A |
$67.57 |
$5,824 |
I/I |
86 |
18,253 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-10-01 |
4 |
A |
$70.35 |
$2,086 |
D/D |
30 |
4,657 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2018-10-01 |
4 |
A |
$70.35 |
$8,231 |
I/I |
117 |
18,370 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2019-01-02 |
4 |
A |
$58.01 |
$8,287 |
I/I |
143 |
18,513 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2019-01-02 |
4 |
A |
$58.01 |
$2,101 |
D/D |
36 |
4,693 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2019-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
601 |
2,654 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2019-04-01 |
4 |
A |
$63.05 |
$926 |
D/D |
15 |
2,669 |
0 |
- |
|
| C |
Citigroup Inc |
Director |
– • – |
2019-04-01 |
4 |
A |
$63.05 |
$9,542 |
I/I |
151 |
21,304 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2016-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,071 |
2,071 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,950 |
4,021 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,410 |
6,431 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,807) |
0 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$180.00 |
$832,320 |
D/D |
(4,624) |
1,807 |
0 |
- |
|
67 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
